Liters

Weekly insights for industry insiders, capital allocators, policy researchers, and anyone who wants to understand the business and economics of the global plasma industry.

Most Recent

Mar 26, 2026

The Plasma Supply Risk Nobody Has Modeled

FDA's staffing crisis has been well documented for drug developers. For the independent operators now carrying plasma's collection growth, the exposure is more specific, less visible, and not yet in any model.

Mar 17, 2026

Five Years, €280 Million, and a Proof of Concept

The Egypt Unlock: Grifols just proved that a compensated, non-Western plasma platform can clear the EMA bar.

Liters

Most Recent

The Plasma Supply Risk Nobody Has Modeled

Five Years, €280 Million, and a Proof of Concept

Get the latest insights delivered to your inbox.

Quick Links

Subscription

Socials